comprehensive -WSS

comprehensive

author：entertainment 2025-10-02 09:39:15 Page View：9394

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Latest bird flu infection made farmworker sicker than earlier cases
Next article： Affirmative action in medical school literally saved lives

focus

Medicare details structure of new drug price negotiation program

MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

David Sabatini, ex

DavidSabatiniposedathishomeinCambridgein2022.CraigF.Walker/BostonGlobeFormerMITandWhiteheadInstitute

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

Antibiotic resistance nearly killed me, so I'm raising awareness of it

AdobeTherearemanyreasonswhypeoplewriteabouttheloomingthreatofantibioticresistance.Academicsdoittosha

comprehensive

explore

focus

Antibiotic resistance nearly killed me, so I'm raising awareness of it